Rankings
▼
Calendar
PRME
Prime Medicine, Inc.
$681M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$3M
EPS (Diluted)
$-0.03
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$156,000
← FY 2019
All Quarters
FY 2020 →
PRME Q4 2019 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
